Loading, please wait....jpg)
.jpg)
The Premier March 27, 2025 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Dont' Get Lost in the Alphabet Soup: Overview of Emerging Cancer Immune Therapies
SPEAKER: Genevieve Kumapley, PharmD, BCOP, Clinical Pharmacy Manager, Holy Name Medical Center, Teaneck, NJ
ACPE Universal Activity Number: 0122-0000-25-006-L01-P/T [0.1 CEU] [1 Contact Hr.]
Date: Mar 27, 2025 12:00 PM - 01:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Mar 27, 2025 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Support/Credits
Premier, Inc. has received no outside support for the administration of this program.
Registration closes on Mar 27, 2025
at 12:10 PM
Registration closes on Mar 27, 2025
at 12:10 PM
Registration Closed
Registration Closed
Objectives
- Describe the new classes of immune-oncology therapies, including their mechanisms of action, indications for use and adverse effects
- Summarize the evidence for new chimeric antigen receptor T-cell therapies, bispecific T-cell engagers and antibody drug conjugates
- Review the management of antibody conjugate and other immune-related adverse effects
Speaker(s)/Author(s)
|
Genevieve Kumapley, PharmD, BCOP
|
Activity Number
0122-0000-25-006-L01-P/T
Date:
03/27/25
Time:
12:00 PM - 01:00 PM
CE Hours
1.00
Registration Closed